Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com.
Enhancing ADC Process Development Through Optimizing DAR Homogeneity, Controlling Impurities & Streamlining Unit Operations to Guarantee Product Quality & Support Regulatory Submissions
Underpinning successful ADC development is a robust, reproducible, and scalable process development strategy. From controlling impurities and optimizing conjugation yield to streamlining unit operations and executing technology transfer, it’s clear that the path to successful commercialization is enabled by a strong process development strategy.
That's why in 2025, the 3rd ADC Process Development Summit was the only meeting dedicated to the technical and strategic challenges of ADC process development. In an intimate setting, you joined 80+ experts from AstraZeneca, Merck, Gilead, Genentech, AbbVie, and more for two days of focused insights, real-world case studies, and peer-led discussion to revolutionize your antibody-drug conjugate manufacturing process.
This was your chance to uncover how to streamline purification strategies, scale up emerging conjugation approaches, define CQA-driven specifications, and scale up manufacturing while meeting evolving regulatory expectations. Whether you’ were supporting early-stage development or preparing for pivotal trials and BLA submissions, this was your opportunity to benchmark, troubleshoot, and advance your ADC process with confidence.
Explore the 2025 Full Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Preview featured case studies that we’ll be shining a light on
- Discover exclusive content such as keynote highlights, attendee benefits and more
2025 World-Class Speaker Faculty Included:
I am excited to engage with colleagues from diverse functions and backgrounds, exchanging insights into the latest advancements in ADC process development. Together, by sharing our expertise and fostering collaboration, we can enhance the ADC pipeline and ensure the continued safety and well-being of patients worldwide.
Laurencia Zongo, Scientist, Purification Process Sciences, AstraZeneca, 2025 Expert Speaker
Official 2025 Partners
Previously Attending Companies Included
Proud to be Part of the World ADC Series:
Designed to make sure ADC experts are up to date with industry's advancements, the World ADC Event Series unites 1,500+ experts in the field to provide valuable insights and connections to advance ADCs as a first-option treatment. From globally leading conferences to webinars and industry reports, whatever the information you need, the 3rd ADC Process Development Summit was one of many events offering you the insights you needed to optimize your purification & conjugation processes, to reduce unit operations whilst retaining drug substance quality to stay ahead of the growing field.
Explore Related Events
Explore the 2025 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.